• All News
• 2019
• 2017
• 2016
• 2015
• 2014

Xenetic Biosciences, Inc. Reports Second Quarter 2019 Financial Results and Provides Corporate Update

Aug 15, 2019

Xenetic Biosciences, Inc. Closes $15.0 Million Underwritten Public Offering and Completes Acquisition of Innovative CAR T Technology Platform

Jul 22, 2019

Xenetic Biosciences, Inc. (Nasdaq: XBIO) Announces Pricing of $15.0 Million Underwritten Public Offering

Jul 17, 2019

Xenetic Biosciences, Inc. Announces Reverse Stock Split of Common Stock

Jun 24, 2019

Xenetic Biosciences, Inc. Reports First Quarter 2019 Financial Results and Provides Corporate Update

May 13, 2019

Xenetic Biosciences, Inc. Strengthens Scientific Advisory Board with Appointment of Guenther Koehne, M.D., Ph.D.

May 2, 2019

Xenetic Biosciences, Inc. Reports 2018 Year End Results and Provides Corporate Update

Apr 1, 2019

Xenetic Biosciences Announces Pricing of $3.1 Million Registered Direct Offering

Mar 5, 2019

Xenetic Biosciences, Inc. (NASDAQ: XBIO) Announces Agreement to Acquire Innovative CAR T Technology Platform

Mar 4, 2019

Xenetic Biosciences Reports 2017 Third Quarter Financial Results and Provides Corporate Update

Nov 15, 2017

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• Next »